Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by GeneralAladeenon Jul 21, 2022 9:46pm
195 Views
Post# 34842101

RE:RE:RE:RE:RE:Don't sell your shares!

RE:RE:RE:RE:RE:Don't sell your shares!

Techone. Nice to hear from you on Spectal board, not only on the NPK - Verde Agritech board (where you input is great) You're one of the few posters on here that I know don't have an agenda. 

Great post! I only have 30,000 shares of EDT, but always interested in releases like yesterdays. Certainly is somewhat anecdotal but nice to see nonetheless. This .54 SP is confusing with all Spectral has going but I will hold to the bitter end to see what comes of this gem? Can't say the company has managed funds particularly well, but they seem to have the holy grail for Sepsis.

We should have the normal run up to FDA decision time (whenever that is) next summer fall? But the real catalyst seems to be either a Baxter Buyout, FDA approval or revenue exploding. Any of those would be nice.

I had a family member die of Sepsis several years ago, so I am always wishing for FDA to approve this game changing device to help other families.   Let hope it's a home run and not another Canadian Biotech dud. My money says winner....we shall see:-) good luck with all your investments!! 

<< Previous
Bullboard Posts
Next >>